Silhouette

LAURENCE H. HURLEY

Tetragene, LLC

Employers

Affiliated Awards

Award Title Agency Phase Award amount Start Date End Date
The Development of Novel Inhibitors of BCL2 Gene Expression as Anticancer Therape
Tetragene, LLC
Principal Investigator
HHS 1 $225K 09/20/14 08/31/15